| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.094 | 0.06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.06 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |